MedPath

Effects of Virtual Reality on Dual Task Performance

Not Applicable
Completed
Conditions
Stroke
Interventions
Other: virtual reality
Other: robotic gait
Registration Number
NCT03845855
Lead Sponsor
Hacettepe University
Brief Summary

This study evaluates the effects of virtual reality treatment in addition to robotic gait therapy on dual task performance, balance and gait in chronic stroke patients. Half of participants will attend virtual reality treatment in addition to robotic gait therapy for 12 sessions, while the other half will attend only robotic gait therapy for 12 sessions.

Detailed Description

Following stroke, motor disorders, balance disorders, falls, gait disturbances and cognitive disorders are frequently seen. In stroke rehabilitation, with the use of robots and virtual reality systems with conventional methods, it is aimed to increase patient's motivation, to check if exercise is effective, to provide objective evaluation data and to support the motor learning process and the use of these methods in the field of neurological rehabilitation is increasing.

Multi-task evaluations can be made with the virtual environments created by virtual reality applications and complex tasks.

The traditional approach to stroke rehabilitation is mainly focused on balance and gait training under single task conditions. In everyday life, people should not only have balance and mobility skills, but also have the ability to perform other cognitive and motor tasks with these skills. Therefore, traditional approaches are not sufficient for the individual to return to society after a stroke.

In this respect, this study was planned in order to examine the effects of frequently used virtual reality treatment in addition to robotic gait therapy on the dual task, balance and gait performance.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Volunteer to participate in the research
  • Stroke for the first time
  • To be able to walk independently before the disease
  • To score 3 or above in the functional ambulation classification
  • 6 months after stroke diagnosis
  • Not having open wounds
  • Severity of spasticity of the lower extremities to be 3 and below according to the Modified Asworth Scale
  • To score 24 or more in the Mini Mental State Examination
Exclusion Criteria
  • Acute internal problems, additional neurological diseases, or orthopedic problems that might limit walking
  • To have received botulinum toxin treatment during 6 months before treatment or during treatment
  • To have stroke on both sides
  • To have neglect

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Virtual reality with robotic gaitrobotic gaitvirtual reality treatment with robotic gait therapy 2 times for week by 6 weeks.
Robotic gait therapy onlyrobotic gaitonly robotic gait therapy 2 times for week by 6 weeks
Virtual reality with robotic gaitvirtual realityvirtual reality treatment with robotic gait therapy 2 times for week by 6 weeks.
Primary Outcome Measures
NameTimeMethod
10 meter walk testchange from baseline time at the end of 6 week

The time is measured after 10 meter walk completed

10 meter walk test with cognitive taskchange from baseline time at the end of 6 week

The time is measured after 10 meter walk with a cognitive task completed

10 meter walk test with motor taskchange from baseline time at the end of 6 week

The time is measured after 10 meter walk with a motor task completed

Secondary Outcome Measures
NameTimeMethod
Berg Balance Scalechange from baseline score at the end of 6 week

The Berg balance scale is used to objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks. It is a 14 item list with each item consisting of a five-point ordinal scale ranging from 0 to 4, with 0 indicating the lowest level of function and 4 the highest level of function.

Falls Efficacy Scale - Internationalchange from baseline score at the end of 6 week

The Falls Efficacy Scale International are measures of "fear of falling" or, more properly, "concerns about falling". Minimum 16 (no concern about falling) to maximum 64 (severe concern about falling) can be obtained.

Functional Ambulation Classificationchange from baseline score at the end of 6 week

This 6-point scale assesses ambulation status by determining how much human support the patient requires when walking, regardless of whether or not they use a personal assistive device. Level 0 is the minimum level and level 5 is the maximum level. Higher levels represent better function.

Rivermead Mobility Indexchange from baseline score at the end of 6 week

Rivermead Mobility Index assesses functional mobility in gait, balance and transfers after stroke. 14-self-reported items and 1 direct observation item are calculated. Items are coded as either 0 or 1, depending on whether the patient can complete the task according to specific instructions. Items receive a score of 0 for a "No" response and 1 for a "Yes" response.A maximum of 15 points is possible; higher scores indicate better mobility performance.

Functional Gait Assessmentchange from baseline score at the end of 6 week

The Funcitonal Gait Assessment is used to assess postural stability during various walking tasks. The highest score is 30/30. Higher scores represent better functional gait performance.

Mini Mental State Examinationchange from baseline score at the end of 6 week

Mini Mental State Examination can be used to assess the mental status. Mini Mental State Examination is an 11-question measure that tests five areas of cognitive function: orientation, registration, attention and calculation, recall, and language. The maximum score is 30. The minimum score is 0. Getting 24 point is cut point. If a person get 24 points from examination, his/her mental status is fine. The higher scores represent better mental status.

Trial Locations

Locations (1)

Kozakli Fizik Tedavi Ve Rehabilitasyon Hastanesi

🇹🇷

Nevşehir, Kozaklı, Turkey

© Copyright 2025. All Rights Reserved by MedPath